Home
International
Politics
Finance
Sports
Entertainment
Technology
Others
×
Site Menu
Home
International
Politics
Finance
Sports
Entertainment
Technology
Investing.com
Stellantis aims to cut North America inventories by 100,000 by early-2025, CFO says
Stellantis aims to cut North America inventories by 100,000 by early-2025, CFO says
Share this!
Chevron transports non-essential personnel from Gulf of Mexico sites due to tropical disturbance
Chevron transports non-essential personnel from Gulf of Mexico sites due to tropical disturbance
Share this!
Northvolt to axe 1,600 jobs as Europe's EV hopes stall
Northvolt to axe 1,600 jobs as Europe's EV hopes stall
Share this!
Northrop Grumman stock soars to 52-week high of $529.58
Northrop Grumman stock soars to 52-week high of $529.58
Share this!
CN Police Services Mobilizing for See Tracks? Think Train ® Week 2024
CN Police Services Mobilizing for See Tracks? Think Train ® Week 2024
Share this!
Global Payments to Host Investor Conference on September 24, 2024
Global Payments to Host Investor Conference on September 24, 2024
Share this!
Point Energy Partners II Completes $1.1 Billion Sale to Vital Energy
Point Energy Partners II Completes $1.1 Billion Sale to Vital Energy
Share this!
Verint and Five9 Deepen Partnership to Deliver AI-Driven Customer Experiences
Verint and Five9 Deepen Partnership to Deliver AI-Driven Customer Experiences
Share this!
Trio-Tech Fourth Quarter Net Income Improves to $0.06 from $0.04 Per Diluted Share
Trio-Tech Fourth Quarter Net Income Improves to $0.06 from $0.04 Per Diluted Share
Share this!
Glimpse Group stock hits 52-week low at $0.73 amid market challenges
Glimpse Group stock hits 52-week low at $0.73 amid market challenges
Share this!
Microsoft shares downgraded to neutral with no change in price target
Microsoft shares downgraded to neutral with no change in price target
Share this!
McKesson stock maintained at Hold as inflation impacts food categories
McKesson stock maintained at Hold as inflation impacts food categories
Share this!
Aligos Therapeutics stock hits 52-week low at $8.5
Aligos Therapeutics stock hits 52-week low at $8.5
Share this!
Macrogenics stock hits 52-week low at $3.14
Macrogenics stock hits 52-week low at $3.14
Share this!
Glaukos stock outlook positive despite AbbVie's new Durysta competitor
Glaukos stock outlook positive despite AbbVie's new Durysta competitor
Share this!
XOMA shares hold as analyst reiterates Buy rating post-FDA nod
XOMA shares hold as analyst reiterates Buy rating post-FDA nod
Share this!
Sprouts Farmers Market stock soars to all-time high of $107.97
Sprouts Farmers Market stock soars to all-time high of $107.97
Share this!
Baird raises Ameresco stock price target on improving energy asset visibility
Baird raises Ameresco stock price target on improving energy asset visibility
Share this!
First
Prev.
1936
1937
1938
1939
1940
1941
1942
Next
Last
Popular
Georgia doctors speak out to challenge misinformation on sta...
4 months ago
Georgia doctors speak out to challenge misinformation on state's abortion law, death of Amber Thurman
Share this!
Pentagon sending a ‘few thousand’ personnel to Middle East d...
4 months ago
Pentagon sending a ‘few thousand’ personnel to Middle East day after Biden said he wouldn’t add combat troops
Share this!
Jimmy Carter becomes first president to turn 100
4 months ago
Jimmy Carter becomes first president to turn 100
Share this!
After Shaq, Jay-Z, Beyonce And Others, Tesla Cybertruck Join...
3 months ago
After Shaq, Jay-Z, Beyonce And Others, Tesla Cybertruck Joins Joins Irvine Police Department's Fleet, Will Be Used For Community Outreach Efforts
Share this!
Scandals, failed assassinations and political rhetoric: Both...
4 months ago
Scandals, failed assassinations and political rhetoric: Both sides go high and low
Share this!
Trending
1.
Palantir stock
2.
PLTR
3.
Claudia Sheinbaum
4.
Department of Education
5.
Chelsea vs West Ham
6.
Valentine's Day gifts
7.
Battlefield Labs
8.
Sovereign wealth fund
9.
Kingdom Come: Deliverance 2
10.
Elon Musk Treasury
© NewsMage 2025. All rights are reserved